[1]
|
Al-Jaghbeer, M., Dealmeida, D., Bilderback, A., Ambrosino, R. and Kellum, J.A. (2018) Clinical Decision Support for In-Hospital AKI. Journal of the American Society of Nephrology, 29, 654-660.
https://doi.org/10.1681/ASN.2017070765
|
[2]
|
Wang, H., Muntner, P., Chertow, G. and Warnock, D.G. (2012) Acute Kidney Injury and Mortality in Hospitalized Patients. American Journal of Nephrology, 35, 349-355. https://doi.org/10.1159/000337487
|
[3]
|
Mehta, R., Pascual, M., Soroko, S., Savage, B.R., Himmelfarb, J., Alp Ikizler, T., et al. (2004) Spectrum of Acute Renal Failure in the Intensive Care Unit: The PICARD Experience. Kidney International, 66, 1613-1621.
https://doi.org/10.1111/j.1523-1755.2004.00927.x
|
[4]
|
Schiffl, H. and Fischer, R. (2008) Five-Year Outcomes of Severe Acute Kidney Injury Requiring Renal Replacement Therapy. Nephrology, Dialysis, Transplantation, 23, 2235-2241. https://doi.org/10.1093/ndt/gfn182
|
[5]
|
Chertow, G., Burdick, E., Honour, M., Bonventre, J.V. and Bates, D.W. (2005) Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients. Journal of the American Society of Nephrology, 16, 3365-3370.
https://doi.org/10.1681/ASN.2004090740
|
[6]
|
Singh, J., Reddy, S. and Kundukulam, J. (2011) Risk Factors for Gout and Prevention: A Systematic Review of the Literature. Current Opinion in Rheumatology, 23, 192-202. https://doi.org/10.1097/BOR.0b013e3283438e13
|
[7]
|
Desideri, G., Virdis, A., Casiglia, E. and Borghi, C. (2018) Exploration into Uric and Cardiovascular Disease: Uric Acid Right for Heart Health (URRAH) Project: A Study Protocol for a Retrospective Observational Study. High Blood Pressure & Cardiovascular Prevention, 25, 197-202. https://doi.org/10.1007/s40292-018-0250-7
|
[8]
|
Li, G., Jiao, X. and Cheng, X. (2018) Correlations between Blood Uric Acid and the Incidence and Progression of Type 2 Diabetes Nephropathy. European Review for Medical and Pharmacological Sciences, 22, 506-511.
|
[9]
|
Feig, D., Kang, D. and Johnson, R. (2008) Uric Acid and Cardiovascular Risk. The New England Journal of Medicine, 359, 1811-1821. https://doi.org/10.1056/NEJMra0800885
|
[10]
|
Ilundain-González, A., Gimeno-Orna, J., Sáenz-Abad, D., Pons-Dolset, J., Cebollada-del Hoyo, J. and del Carmen Lahoza-Pérez, M. (2018) Impact of Uric Acid Levels on the Risk of Long-Term Cardiovascular Mortality in Patients with Type 2 Diabetes Mellitus. Endocrinología, Diabetes y Nutrición, 65, 335-341.
https://doi.org/10.1016/j.endinu.2018.01.004
|
[11]
|
Liu, W., Hung, C., Chen, S., Yeh, S.-M., Lin, M.-Y., Chiu, Y.-W., et al. (2012) Association of Hyperuricemia with Renal Outcomes, Cardiovascular Disease, and Mortality. Clinical Journal of the American Society of Nephrology, 7, 541-548. https://doi.org/10.2215/CJN.09420911
|
[12]
|
Kim, C., Jin, D., Yun, Y., Bae, E.H., Ma, S.K. and Kim, S.W. (2017) Relationship between Serum Uric Acid and Mortality among Hemodialysis Patients: Retrospective Analysis of Korean End-Stage Renal Disease Registry Data. Kidney Research and Clinical Practice, 36, 368-376. https://doi.org/10.23876/j.krcp.2017.36.4.368
|
[13]
|
Kang, M., Chin, H., Joo, K., Na, K.Y., Kim, S. and Han, S.S. (2019) Hyperuricemia Is Associated with Acute Kidney Injury and All-Cause Mortality in Hospitalized Patients. Nephrology, 24, 718-724. https://doi.org/10.1111/nep.13559
|
[14]
|
Zhao, G., Xu, C., Ying, J., Lv, W., Hong, G., Li, M., et al. (2020) Association between Furosemide Administration and Outcomes in Critically Ill Patients with Acute Kidney Injury. Critical Care, 24, Article No. 75.
https://doi.org/10.1186/s13054-020-2798-6
|
[15]
|
徐夏莲, 许佳瑞, 王一梅, 耿雪梅, 陈欣, 章晓燕, 等. 术前血尿酸水平对心脏手术术后急性肾损伤发生的影响[J]. 中国临床医学, 2019, 26(3): 450-455.
|
[16]
|
Hoste, E., Clermont, G., Kersten, A., Venkataraman, R., Angus, D.C., De Bacquer, D., et al. (2006) RIFLE Criteria for Acute Kidney Injury Are Associated with Hospital Mortality in Critically Ill Patients: A Cohort Analysis. Critical Care, 10, Article No. R73. https://doi.org/10.1186/cc4915
|
[17]
|
Doi, K. and Rabb, H. (2016) Impact of Acute Kidney Injury on Distant Organ Function: Recent Findings and Potential Therapeutic Targets. Kidney International, 89, 555-564. https://doi.org/10.1016/j.kint.2015.11.019
|
[18]
|
Zheng, C., Liu, W., Zeng, F., Zheng, M., Shi, H., Zhou, Y., et al. (2017) Prognostic Value of Platelet-to-Lymphocyte Ratios among Critically Ill Patients with Acute Kidney Injury. Critical Care, 21, Article No. 238.
https://doi.org/10.1186/s13054-017-1821-z
|
[19]
|
Balta, S., Demırkol, S. and Kucuk, U. (2013) The Platelet Lymphocyte Ratio May Be Useful Inflammatory Indicator in Clinical Practice. Hemodialysis International, 17, 668-669. https://doi.org/10.1111/hdi.12058
|
[20]
|
Hahn, K., Kanbay, M., Lanaspa, M., Johnson, R.J. and Ahsan Ejaz, A. (2017) Serum Uric Acid and Acute Kidney Injury: A Mini Review. Journal of Advanced Research, 8, 529-536. https://doi.org/10.1016/j.jare.2016.09.006
|
[21]
|
Deswal, A., Petersen, N., Feldman, A., Young, J.B., White, B.G. and Mann, D.L. (2001) Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST). Circulation, 103, 2055-2059. https://doi.org/10.1161/01.CIR.103.16.2055
|
[22]
|
Pierce, C. and Larson, D. (2005) Inflammatory Cytokine Inhibition of Erythropoiesis in Patients Implanted with a Mechanical Circulatory Assist Device. Perfusion, 20, 83-90. https://doi.org/10.1191/0267659105pf793oa
|
[23]
|
Grander, W., Dünser, M., Stollenwerk, B., Siebert, U., Dengg, C., Koller, B., Eller, P., et al. (2010) C-Reactive Protein Levels and Post-ICU Mortality in Nonsurgical Intensive Care Patients. Chest, 138, 856-862.
https://doi.org/10.1378/chest.09-1677
|
[24]
|
Susic, D. and Frohlich, E. (2015) Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment. Cardiorenal Medicine, 5, 175-182. https://doi.org/10.1159/000381317
|
[25]
|
Li, L., Yang, C., Zhao, Y., Zeng, X., Liu, F. and Fu, P. (2014) Is Hyperuricemia an Independent Risk Factor for New-Onset Chronic Kidney Disease? A Systematic Review and Meta-Analysis Based on Observational Cohort Studies. BMC nephrology, 15, Article No. 122. https://doi.org/10.1186/1471-2369-15-122
|
[26]
|
Ali, T., Khan, I., Simpson, W., Prescott, G., Townend, J., Smith, W., et al. (2007) Incidence and Outcomes in Acute Kidney Injury: A Comprehensive Population-Based Study. Journal of the American Society of Nephrology, 18, 1292-1298. https://doi.org/10.1681/ASN.2006070756
|
[27]
|
Wu, V., Huang, T., Lai, C., Shiao, C.-C., Lin, Y.-F., Chu, T.-S., et al. (2011) Acute-on-Chronic Kidney Injury at Hospital Discharge Is Associated with Long-Term Dialysis and Mortality. Kidney International, 80, 1222-1230.
https://doi.org/10.1038/ki.2011.259
|
[28]
|
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kocak Kadioglu, G., Kirbas, I., et al. (2011) A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function. Clinical journal of the American Society of Nephrology, 6, 1887-1894.
https://doi.org/10.2215/CJN.11451210
|
[29]
|
Erol, T., Tekin, A., Katırcıbaşı, M., Sezgin, N., Bilgi, M., Tekin, G., et al. (2013) Efficacy of Allopurinol Pretreatment for Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial. International Journal of Cardiology, 167, 1396-1399. https://doi.org/10.1016/j.ijcard.2012.04.068
|
[30]
|
Kumar, A., Bhawani, G., Kumari, N., Murthy, K.S.N., Lalwani, V. and Narasimha Raju, C.H. (2014) Comparative Study of Renal Protective Effects of Allopurinol and N-Acetyl-Cysteine on Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization. Journal of Clinical and Diagnostic Research, 8, HC03-HC07.
https://doi.org/10.7860/JCDR/2014/9638.5255
|
[31]
|
Kanbay, M., Ozkara, A., Selcoki, Y., Isik, B., Turgut, F., Bavbek, N., et al. (2007) Effect of Treatment of Hyperuricemia with Allopurinol on Blood Pressure, Creatinine Clearence, and Proteinuria in Patients with Normal Renal Functions. International Urology and Nephrology, 39, 1227-1233. https://doi.org/10.1007/s11255-007-9253-3
|
[32]
|
Talaat, K. and el-Sheikh, A. (2007) The Effect of Mild Hyperuricemia on Urinary Transforming Growth Factor Beta and the Progression of Chronic Kidney Disease. American Journal of Nephrology, 27, 435-440.
https://doi.org/10.1159/000105142
|
[33]
|
Whelton, A., Macdonald, P., Zhao, L., Hunt, B. and Gunawardhana, L. (2011) Renal Function in Gout: Long-Term Treatment Effects of Febuxostat. Journal of Clinical Rheumatology, 17, 7-13.
https://doi.org/10.1097/RHU.0b013e318204aab4
|